Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Raschi

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Journal of Biological Regulators and Homeostatic Agents|May 16, 1998
Is there any pathogenic role for the anti-endothelial cell antibodies (AECA) in autoimmune vasculitis?P L Meroni, N Del Papa, E Raschi, et al.
Immunology Letters|August 30, 2000
Anti-endothelial cell antibodies in patients with coronary atherosclerosisJ George, P L Meroni, B Gilburd, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 13, 2016
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting SystemE Raschi, E Poluzzi, A Koci, et al.
Lupus|October 2, 2008
Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndromeE Raschi, M O Borghi, C Grossi, et al.
Italian Journal of Pediatrics|April 18, 2017
Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unitA Girardi, S Galletti, E Raschi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 8, 2018
Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systemsE Raschi, E Poluzzi, F Salvo, et al.
Lupus|May 29, 2012
Obstetric and vascular APS: same autoantibodies but different diseases?P L Meroni, E Raschi, C Grossi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 28, 2017
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systemsE Raschi, M Parisotto, E Forcesi, et al.
International Journal of Clinical Practice|January 12, 2013
Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implicationsM Bennie, I Bishop, B Godman, et al.
Cephalalgia : an International Journal of Headache|September 24, 2014
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studiesG Roberto, E Raschi, C Piccinni, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of Biological Regulators and Homeostatic Agents|May 16, 1998
Is there any pathogenic role for the anti-endothelial cell antibodies (AECA) in autoimmune vasculitis?P L Meroni, N Del Papa, E Raschi, et al.
Immunology Letters|August 30, 2000
Anti-endothelial cell antibodies in patients with coronary atherosclerosisJ George, P L Meroni, B Gilburd, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 13, 2016
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting SystemE Raschi, E Poluzzi, A Koci, et al.
Lupus|October 2, 2008
Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndromeE Raschi, M O Borghi, C Grossi, et al.
Italian Journal of Pediatrics|April 18, 2017
Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unitA Girardi, S Galletti, E Raschi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 8, 2018
Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systemsE Raschi, E Poluzzi, F Salvo, et al.
Lupus|May 29, 2012
Obstetric and vascular APS: same autoantibodies but different diseases?P L Meroni, E Raschi, C Grossi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 28, 2017
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systemsE Raschi, M Parisotto, E Forcesi, et al.
International Journal of Clinical Practice|January 12, 2013
Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implicationsM Bennie, I Bishop, B Godman, et al.
Cephalalgia : an International Journal of Headache|September 24, 2014
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studiesG Roberto, E Raschi, C Piccinni, et al.
Pageof 4